Corrigendum: Perspective: A Framework to Screen Pediatric and Adolescent Hematopoietic Cellular Therapy Patients for Organ Dysfunction: Time for a Multi-Disciplinary and Longitudinal Approach (Frontiers in Oncology, (2021), 11, (622630), 10.3389/fonc.2021.622630)

In the original article, there was a mistake in Table 2. Possible Screening for pMODS for Pediatric and Adolescent-Young Adult (AYA) HCT Patients as published. The following in Table 2 has been corrected: Respiratory: Score 0 and Score 2; CV: Score 2; Renal: Score 4; Hematologic: Score 0, Score 1, Score 2, and Score 3; CNS: Score 0 and Score 4; Immune Reconstitution: Score 1 and Score 2 and Footnote f. The corrected Table 2. Possible Screening for pMODS for Pediatric and Adolescent-Young Adult (AYA) HCT Patients appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. (Table presented.).

Duke Scholars

Author Kris Mahadeo Pediatrics, Transplant and Cellular Therapy